Poster Presentations: Wednesday, October 26, 2011 |

Intraoperative Infusion of Landiolol Hydrochloride, an Ultra-Short Acting Beta-1 Adrenergic Receptor Blocker, Prevents Postoperative Atrial Fibrillation After Off-Pump Coronary Artery Bypass Surgery FREE TO VIEW

Hiroki Wakamatsu, PhD; Hitoshi Yokoyama, PhD
Author and Funding Information

Fukushima Medical University, Fukushima, Japan

Chest. 2011;140(4_MeetingAbstracts):508A. doi:10.1378/chest.1083237
Text Size: A A A
Published online


PURPOSE: Postoperative atrial fibrillation (AF) is associated with adverse effects after coronary artery bypass surgery. The aim of this study was to evaluate the effect of intraoperative infusion of landiolol hydrochloride, a novel ultra-short acting beta-1 adrenergic receptor blocker, for post-operative AF after off-pump coronary artery bypass (OPCAB) surgery.

METHODS: One hundred forty patients who underwent OPCAB were analyzed retrospectively. Landiolol group (Group L: n=68) was compared with control group (Group C: n=72). In group L, landiolol was infused after sternotomy, starting at 1 μg/kg/min. The dose was increased as long as the systolic pressure was maintained above 100 mmHg. The infusion was continued until the end of the day of surgery.

RESULTS: Average age (years) in both groups was similar (70±9 in group C vs. 67±7 in group L; P=0.254). The average maximum dose of landiolol was 4.7μg/ kg/min. Systolic blood pressure (mmHg) at the left anterior descending artery anastomosis were similar (109±17 vs. 108±8, P=0.740). Heart rate (beats/minute) was significantly decreased in group L (80±14 vs. 65±10; P=0.003). Profound hypotension/bradycardia were not observed during OPCAB. Postoperatively, AF was observed in 25 patients (34.7%) in group C and 12 patients (17.6%) in group L (P=0.022). Postoperative stroke was noticed in 2 patient (2.9%) in group C, and zero in group L (P=0.313). More than three anti-AF agents were needed in 11 patients (44% of AF patients) in group C, while one (8%) in group L (P = 0.030). AF lengthened more than 24 hours was observed in 7 patients (28%) in group C, while no patient in group L (P = 0.041).

CONCLUSIONS: Intra-operative infusion of landiolol hydrochloride decreased the incidence of postoperative AF after OPCAB surgery. This regimen was also associated with early conversion of postoperative AF to sinus rhythm.

CLINICAL IMPLICATIONS: Intraoperative landiolol infusion is safe, and may improve the results of OPCAB by preventing postoperative AF.

DISCLOSURE: The following authors have nothing to disclose: Hiroki Wakamatsu, Hitoshi Yokoyama

No Product/Research Disclosure Information

09:00 AM - 10:00 AM




Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
Intraoperative Interventions*: American College of Chest Physicians Guidelines for the Prevention and Management of Postoperative Atrial Fibrillation After Cardiac Surgery
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543